The final milestone of FDA’s Drug Supply Chain Security Act (DSCSA) will go into effect in November 2023. During this webinar, attendees will learn what the deadline means for trading partners across the supply chain and how to prepare for the upcoming requirements. Panelists will help to answer questions that many trading partners may have, including:
- What is DSCSA?
- How will DSCSA affect trading partners?
- What new requirements will go into effect?
- What resources are available?
- How will DSCSA further protect patients?
- How is NABP working to help state regulators and trading partners prepare?
This webinar is a recording of the live session that was held on July 11, 2023.
This webinar is not eligible for Accreditation Council for Pharmacy Education-accredited continuing pharmacy education credit.
RegisterIlisa Bernstein, PharmD, JD, FAPhA, Interim Executive Vice President and CEO, American Pharmacists Association
Ilisa Bernstein is currently the Interim Executive Vice President and CEO at the American Pharmacists Association (APhA). She is responsible for leading the development and implementation of APhA’s strategies related to pharmacy practice and professional affairs, advocacy, and government affairs.
She has over 30 years of experience advocating for pharmacy and patients at Food and Drug Administration (FDA), where she held several senior leadership positions. Most recently, Dr Bernstein was deputy director of FDA’s Office of Compliance in the Center for Drug Evaluation and Research, leading policies, compliance, and enforcement in areas including drug compounding, supply chain security, drug manufacturing and quality, drug shortages, and post-market drug safety.
Dr Bernstein also served as director of pharmacy affairs for FDA and senior advisor for regulatory policy in the Office of the Commissioner. She started at FDA as a clinical pharmacology reviewer of investigational and new drug applications.
Previously, Dr Bernstein was senior associate director of worldwide regulatory affairs for Pfizer and completed a post-doctoral clinical residency at the National Institutes of Health. She earned her doctor of pharmacy degree from the University of Michigan and her juris doctor degree from American University Washington College of Law.
Scott Mooney, MBA, Vice President Distribution Operations, Traceability, McKesson
Scott Mooney currently serves as vice president of distribution operations at McKesson Corporation where his primary responsibilities include ensuring product integrity through regulatory compliance and traceability. Mr Mooney has been leading this effort since 2013 with McKesson’s Traceability Team working on implementation across McKesson’s various business units. McKesson, while primarily known as a distributor, also operates as a generic pharmaceutical manufacturer, a third-party logistics provider, and a dispenser providing a full spectrum view on the pharmaceutical supply chain.
Mr Mooney joined McKesson in 1987 and had previous roles in finance, distribution center management, and as a regional vice president of distribution operations. He has participated in McKesson’s integration of acquisitions over the last 15 years.
Mr Mooney has been active in the Healthcare Distribution Alliance’s (HDA’s) Traceability Workgroup in addition to serving on the HDA Industry Relations Council. He is also engaged in several HDA committees, including the Federal Issues Task Force, the Regulatory Issues Task Force, and State Government Affairs. Scott is co-chair of the GS1 Global Healthcare Leadership Team and is on the GS1 US Healthcare Executive Leadership Team. GS1 and GS1 US are standards organizations governing bar coding and data exchange standards. He also serves as a member of the board of directors for the Partnership for DSCSA Governance.
Mr Mooney has a bachelor’s degree in accountancy and a master’s in business administration from the University of Wisconsin – La Crosse.
Aaron Weisbuch, JD, Senior Regulatory Advisor, Food and Drug Administration Center for Drug Evaluation Research Office of Drug Security, Integrity, and Response
Josh Bolin, Associate Executive Director, Government Affairs and Innovation
Josh Bolin serves as the associate executive director for federal affairs and strategy for NABP. Since joining the Association in 2005, Mr Bolin has worked on the development of NABP PMP InterConnect®, accreditation programs for durable medical equipment and specialty pharmacy, and inspection programs for the prescription drug supply chain, sterile and nonsterile compounding, and nuclear pharmacy. In his federal affairs capacity, Mr Bolin works to provide technical assistance and guidance on behalf of NABP to Congress and federal agencies including Food and Drug Administration, Drug Enforcement Administration, the White House Office of National Drug Control Policy, and others. Prior to joining NABP, Mr Bolin served as the executive director for the Indiana Board of Pharmacy.
Register for the Webinar
Complete the form to register for our on-demand webinars for drug supply chain trading partners. After completing the form, you will receive a confirmation email with access information.